*

Hitt og þetta 17. ágúst 2007

aap: Withdrawal of Motions for the August 27, 2007 Shareholders' Meeting

aap Implantate AG, a medical technology company listed on the Frankfurt Stock Exchange in the Prime Standard segment, was intending to table at the Annual General Meeting on August 27 a number of motions in connection with the company's restructuring and its future focus on biological implants business. The company's Supervisory Board and Management Board now announce that they will dispense for the time being with votes on the following motions: * Agenda Item No. 4 - Resolution to change the company's name * Agenda Item No. 5 - Resolution to change the company's purpose * Agenda Item No. 6 - Resolution to approve a divestiture and takeover agreement * Agenda Item No. 7 - Resolution to approve an intercompany agreement aap is planning within the next 12 months to focus the company on the biological implants segment. In their analysis of possible strategic options to spin off or sell the Trauma & Orthopaedics division, aap Implantate AG's executive bodies came to the conclusion that transferring this division to a separate subsidiary at the present time might lead to negative fiscal consequences arising from the pursuit of individual future alternatives. The Management Board and Supervisory Board intend to present to an extraordinary general meeting to be called at a later date an overall concept that maximizes share value. - aap is a medical technology company that develops, manufactures and markets biomaterials and implants for trauma and orthopaedics. Its product portfolio includes bone cements, bone graft substitutes, antibiotical carriers, implants for fracture healing and joint replacement. In addition to its Berlin headquarters the company has locations in Dieburg and Obernburg near Frankfurt am Main as well as at Nijmegen in the Netherlands. aap Implantate AG has been listed in the Prime Standard segment at the Frankfurt stock exchange since May 16, 2003. Please address any queries to: aap Implantate AG, Nanette Hüdepohl, Investor & Public Relations, Lorenzweg 5, 12099 Berlin, Germany Tel.: +49 30 7501 9133; fax: +49 30 7501 9290; n.huedepohl@aap.de --- End of Message --- aap Implantate AG Lorenzweg 5 Berlin Germany WKN: 506660; ISIN: DE0005066609; Index: CDAX, Prime All Share, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart;